Integer Holdings Corp is a US-listed company in the health care equipment industry. Its financial year ends in December.
Loading chart…
Third-party market data · may be delayed
Under review: our cash-flow value ($22.39) was left out of our combined valuation (it is 0.18x the share price, outside the 0.2-5x range we accept), so it can't be the basis of a rating.
Under review: our cash-flow value ($22.39) was left out of our combined valuation (it is 0.18x the share price, outside the 0.2-5x range we accept), so it can't be the basis of a rating. We'll show the comparison once resolved.
Integer Holdings Corp valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months to October 2026 was $1.83bn, down 0.3% on a year earlier, against growth of 2.7% a quarter earlier. Free-cash-flow margin fell to 4.5% from 6.6% a year earlier. Operating margin narrowed to 8.2% from 12.1%.
Our model value for Integer Holdings is under review, so past values are not shown until it is resolved.
Source: 10-Q filed October 29, 2026 on SEC EDGAR · Financials · Valuation
Integer Holdings generated $1.83bn in revenue over the twelve months to July 2026, down 0.3% on a year earlier and a sharp reversal from the 2.7% growth recorded a quarter earlier. That leaves the company ranked 48th of 58 for growth among the health care equipment firms we cover. Profitability also weakened: free-cash-flow margin slipped to 4.5% from 6.6%, while operating margin narrowed to 8.2% from 12.1%. Even so, the fundamentals grade improves from D to C. Our model value eases from $34.69 to $33.14 a share, well below the current price of $127. The rating remains Sell. At that price, the market appears to be pricing in cash-flow growth of about 20.5% a year for five years, far ahead of the 8.4% a year revenue growth actually delivered.
Revenue for the twelve months to July 2026 was $1.84bn, up 2.7% on a year earlier, slower than the 6.3% growth a quarter earlier. That puts it 22 of 25 for growth among the health care equipment companies we cover. Free-cash-flow margin held at 6.1%. Operating margin narrowed to 9.7% from 12.5%. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 1 of our 7 financial-health checks. At that price, our model says the market is pricing in about 20.5% a year of cash-flow growth for five years, faster than the 8.6% a year revenue growth it has delivered.
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Integer Holdings Corp's trailing-twelve-month revenue fell 0.3% year on year, with a free-cash-flow margin of 4.5%. Where it stands out: stock pay as % of revenue of 1.3% ranks 16 of 123 health care equipment companies we cover. Where it lags: gross margin of 24.6% ranks 111 of 123 health care equipment companies we cover.
Our discounted-cash-flow model values the business at ~$22 per share in the base case (~$7.8–$42 across growth scenarios) — model values under stated assumptions, not a price target.
Current signal Free cash flow diverging from earnings: TTM free cash flow fell 32.6% while net income grew 19.3%: a 52pp divergence.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Nothing in Integer Holdings Corp's latest figures clears our strength thresholds.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
Our value per share comes from a discounted-cash-flow model of Integer Holdings Corp's free cash flow after stock-based pay ( $109M, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.
The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.
We value Integer Holdings Corp as an operating company, with every model that fits that kind of business. Cost of equity 8.6%: the 10-year Treasury yield (4.9%) plus a beta of 0.82 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. | ~$22 ~$7.8–$42 | Left out: out of range vs price (0.18x) |
| Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$110 ~$99–$180 | Left out: far from the other models (more than 3x away from their median) |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$33 ~$21–$53 | Included |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$27 ~$23–$32 | Included |
| Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. | — | Combined value withheld. Review the individual models and their assumptions. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Integer Holdings Corp with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
| At fiscal year end | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Now |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | $47.86 | $29.45 | $45.30 | $76.03 | $80.43 | $81.19 | $85.59 | $68.46 | $99.08 | $132.52 | $78.43 | $126.55 |
| Market value | $1.3bn | $912m | $1.5bn | $2.5bn | $2.7bn | $2.7bn | $2.8bn | $2.3bn | $3.3bn | $4.7bn | $2.8bn | $4.4bn |
| + Net debt (− = net cash) | $1.7bn | $1.7bn | $1.6bn | $900m | $801m | $682m | $810m | $907m | $950m | $954m | $1.2bn | $1.2bn |
| Enterprise value | $2.9bn | $2.6bn | $3.0bn | $3.4bn | $3.5bn | $3.4bn | $3.7bn | $3.2bn | $4.3bn | $5.7bn | $4.0bn | $5.7bn |
| Multiples | ||||||||||||
| Price / sales | 1.6x | 0.8x | 1.3x | 2.0x | 2.1x | 2.5x | 2.3x | 1.7x | 2.2x | 2.8x | 1.5x | 2.4x |
| Price / earnings | — | 153.0x | 21.8x | 14.8x | 27.6x | 34.8x | 29.4x | 34.4x | 36.9x | 39.4x | 27.2x | 42.8x |
| Price / free cash flow | — | 19.4x | 14.2x | 20.2x | 22.7x | 20.0x | 27.6x | 54.8x | 55.5x | 47.3x | 26.6x | 54.3x |
| EV / EBITDA | 50.9x | 14.1x | 13.2x | 13.8x | 14.7x | 16.9x | 16.8x | 15.6x | 16.4x | 17.8x | 11.3x | 19.5x |
Moderate moat
How hard Integer Holdings's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
Cash operating profit has been a median 7.6% of total assets over 10 years.
Gross margin has been a median 27.0%, moving by 1.9 percentage points (standard deviation) across 10 years.
Operating margin has been a median 10.8%; its worst year was 8.2%.
Free cash flow was positive in 10 of 10 years, at a median 7.7% of revenue.
The diluted share count rose 5.6% over five years; stock-based pay has been a median 1.3% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $6.16 | −4% | $1.8bn | −2% |
| Next | $6.87 | +12% | $1.9bn | +6% |
Next year's EPS estimate has moved +0.7% in 90 days, across 9 analysts.
The consensus EPS forecast for the current fiscal year is +1.3% on 90 days ago. In the last 30 days, 3 analysts raised Integer Holdings Corp's forecast and 0 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $6.08 | $6.82 |
| 60 days ago | $6.16 | $6.87 |
| 30 days ago | $6.16 | $6.87 |
| 7 days ago | $6.16 | $6.87 |
| Now | $6.16 | $6.87 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Sept 2026 | $1.68 | $1.34 | −20.4% |
| Jun 2026 | $1.38 | $1.60 | +15.8% |
| Mar 2026 | $1.19 | $1.20 | +1.1% |
| Dec 2025 | $1.70 | $1.76 | +3.6% |
Adjusted EPS as companies report it, against the average analyst estimate.
Our cash-flow model grows Integer Holdings Corp's revenue by +3.9% next year and +4.1% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+4.2%, weight 68%) and the company's own record (+3.2%, weight 32%) . How the weights are set.
Last 12 months +96.0%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $1.8bn | $1.8bn | +2.7% |
| Net margin | 4.6% | 7.0% | +51.2% |
| P/E multiple | 27.7x | 34.8x | +25.8% |
| Share count | 35m | 35m | +0.3% |
Biggest factor: net margin.
Last 3 years +46.3%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $1.4bn | $1.8bn | +27.2% |
| Net margin | 4.9% | 7.0% | +41.7% |
| P/E multiple | 40.7x | 34.8x | −14.5% |
| Share count | 34m | 35m | −5.2% |
Biggest factor: net margin.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| ITGR | +5% | −20% | +45% | +34% | −41% | +61% |
| Industry peers (median) | −9% | −37% | −9% | −20% | −16% | −15% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| ITGR | 67% | 33% | 67% | 58% | 42% | 82% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| ITGR | −20% | −42% | −26% | −15% | −56% | −7% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since November 2, 2015: 67% from December 1, 2015 to October 27, 2016. Getting back needed a 203% gain, reached on March 12, 2018, 501 days after the low.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| October 29, 2026 | 0.0% | −2.1% | — | — |
| August 3, 2026 | +3.2% | +3.3% | +3.2% | +3.4% |
| April 30, 2026 | +0.4% | +1.3% | +5.1% | +7.8% |
| February 19, 2026 | −1.9% | +0.5% | +0.3% | −2.8% |
| October 23, 2025 | −33.2% | +1.4% | −42.0% | −35.8% |
| July 24, 2025 | −6.3% | +0.5% | −6.3% | −4.5% |
| April 24, 2025 | +2.4% | +2.8% | +4.2% | −1.8% |
| February 20, 2025 | −9.3% | −2.1% | −13.6% | −19.6% |
| October 24, 2024 | −0.6% | +0.2% | −1.8% | +9.2% |
| July 25, 2024 | −6.2% | +0.6% | −6.7% | +1.7% |
| April 25, 2024 | −11.1% | +0.6% | −10.8% | −0.5% |
| February 15, 2024 | −5.4% | +0.2% | −2.9% | +8.0% |
Source: SEC EDGAR filings. Retrieved October 30, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY23 Q4 | $1.6B |
| FY24 Q1 | $1.6B |
| FY24 Q2 | $1.6B |
| FY24 Q3 | $1.7B |
| FY24 Q4 | $1.7B |
| FY25 Q1 | $1.7B |
| FY25 Q2 | $1.8B |
| FY25 Q3 | $1.8B |
| FY25 Q4 | $1.9B |
| FY26 Q1 | $1.9B |
| FY26 Q2 | $1.8B |
| FY26 Q3 | $1.8B |
Source: SEC EDGAR filings. Retrieved October 30, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY23 Q4 | 18.7% |
| FY24 Q1 | 15.0% |
| FY24 Q2 | 13.0% |
| FY24 Q3 | 11.2% |
| FY24 Q4 | 8.6% |
| FY25 Q1 | 8.5% |
| FY25 Q2 | 9.6% |
| FY25 Q3 | 9.5% |
| FY25 Q4 | 8.0% |
| FY26 Q1 | 6.3% |
| FY26 Q2 | 2.7% |
| FY26 Q3 | -0.3% |
Source: SEC EDGAR filings. Retrieved October 30, 2026.
| Period | Operating margin (TTM) |
|---|---|
| FY23 Q4 | 10.6% |
| FY24 Q1 | 10.7% |
| FY24 Q2 | 11.3% |
| FY24 Q3 | 11.6% |
| FY24 Q4 | 12.1% |
| FY25 Q1 | 12.5% |
| FY25 Q2 | 12.5% |
| FY25 Q3 | 12.1% |
| FY25 Q4 | 11.9% |
| FY26 Q1 | 11.0% |
| FY26 Q2 | 9.7% |
| FY26 Q3 | 8.2% |
Source: SEC EDGAR filings. Retrieved October 30, 2026.
| Period | FCF margin (TTM) |
|---|---|
| FY23 Q4 | 3.8% |
| FY24 Q1 | 4.5% |
| FY24 Q2 | 4.0% |
| FY24 Q3 | 4.4% |
| FY24 Q4 | 5.8% |
| FY25 Q1 | 6.4% |
| FY25 Q2 | 6.7% |
| FY25 Q3 | 6.6% |
| FY25 Q4 | 5.7% |
| FY26 Q1 | 5.4% |
| FY26 Q2 | 6.1% |
| FY26 Q3 | 4.5% |
Each dollar Integer Holdings took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.
| Revenue | $1.9B | |
|---|---|---|
| Cost of revenue | $1.4B | 73.0% of revenue |
| Gross profit | $500M | 27.0% of revenue |
| Research and development | $49.5M | 2.7% of revenue |
| Selling, general and admin | $212M | 11.4% of revenue |
| Other operating costs | $17.9M | 1.0% of revenue |
| Operating income | $221M | 11.9% of revenue |
| Income tax | $22.6M | 1.2% of revenue |
| Interest and other | $95.9M | 5.2% of revenue |
| Net income | $103M | 5.5% of revenue |
| Fiscal year | 2009 Jan 2010 | 2010 Dec 2010 | 2011 Dec 2011 | 2012 Dec 2012 | 2013 Jan 2014 | 2014 Jan 2015 | 2015 Jan 2016 | 2016 Dec 2016 | 2017 Dec 2017 | 2018 Dec 2018 | 2019 Dec 2019 | 2020 Dec 2020 | 2021 Dec 2021 | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 | LTM Oct 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||
| Revenue | 522 | 533 | 569 | 646 | 664 | 688 | 800 | 1,076 | 1,136 | 1,215 | 1,258 | 1,073 | 1,221 | 1,331 | 1,556 | 1,717 | 1,854 | 1,825 |
| Gross profit | 166 | 174 | 180 | 202 | 219 | 231 | 235 | 338 | 354 | 363 | 355 | 286 | 337 | 346 | 410 | 459 | 500 | 449 |
| EBITDA | 48 | 105 | 98 | 72 | 97 | 113 | 58 | 183 | 228 | 245 | 236 | 200 | 217 | 205 | 262 | 319 | 352 | 290 |
| Operating income | 1 | 69 | 62 | 26 | 61 | 76 | 13 | 93 | 126 | 156 | 158 | 121 | 136 | 113 | 163 | 208 | 221 | 151 |
| Net income | −9 | 33 | 33 | −5 | 36 | 55 | −8 | 6 | 67 | 168 | 96 | 77 | 97 | 66 | 91 | 120 | 103 | 104 |
| Diluted EPS | −$0.39 | $1.40 | $1.40 | −$0.20 | $1.43 | $2.14 | −$0.29 | $0.19 | $2.08 | $5.15 | $2.92 | $2.33 | $2.91 | $1.99 | $2.69 | $3.36 | $2.89 | $2.96 |
| Growth (year on year) | ||||||||||||||||||
| Revenue | — | +2.2% | +6.6% | +13.6% | +2.7% | +3.6% | +16.4% | +34.4% | +5.6% | +6.9% | +3.5% | −14.7% | +13.8% | +9.0% | +16.9% | +10.3% | +8.0% | −0.3% |
| EBITDA | — | +117.0% | −6.4% | −26.3% | +34.8% | +16.0% | −48.8% | +217.5% | +24.5% | +7.0% | −3.7% | −15.1% | +8.6% | −5.7% | +28.1% | +21.8% | +10.2% | −16.3% |
| Operating income | — | — | −10.6% | −58.2% | +137.6% | +23.3% | −82.6% | — | +35.2% | +23.8% | +1.3% | −23.5% | +12.5% | −17.0% | +44.9% | +27.5% | +6.3% | −32.3% |
| Net income | — | — | −0.0% | −114.5% | — | +52.9% | −113.7% | — | — | +151.9% | −42.6% | −19.8% | +25.3% | −31.4% | +36.6% | +32.3% | −14.3% | +19.3% |
| Diluted EPS | — | — | 0.0% | −114.3% | — | +49.7% | −113.6% | — | — | +147.6% | −43.3% | −20.2% | +24.9% | −31.6% | +35.2% | +24.9% | −14.0% | +20.3% |
| Margins | ||||||||||||||||||
| Gross margin | 31.9% | 32.5% | 31.7% | 31.2% | 33.0% | 33.6% | 29.4% | 31.4% | 31.2% | 29.8% | 28.2% | 26.6% | 27.6% | 26.0% | 26.3% | 26.7% | 27.0% | 24.6% |
| EBITDA margin | 9.3% | 19.6% | 17.2% | 11.2% | 14.7% | 16.4% | 7.2% | 17.1% | 20.1% | 20.1% | 18.7% | 18.6% | 17.8% | 15.4% | 16.9% | 18.6% | 19.0% | 15.9% |
| Operating margin | 0.2% | 12.9% | 10.8% | 4.0% | 9.2% | 11.0% | 1.6% | 8.6% | 11.1% | 12.8% | 12.5% | 11.2% | 11.1% | 8.5% | 10.5% | 12.1% | 11.9% | 8.2% |
| Net margin | −1.7% | 6.2% | 5.8% | −0.7% | 5.5% | 8.1% | −0.9% | 0.6% | 5.9% | 13.8% | 7.7% | 7.2% | 7.9% | 5.0% | 5.8% | 7.0% | 5.5% | 5.7% |
| Free-cash-flow margin | 10.0% | 11.4% | 11.9% | 3.7% | 5.7% | 8.2% | −4.0% | 4.4% | 9.0% | 10.1% | 9.3% | 12.5% | 8.5% | 3.1% | 3.9% | 5.8% | 5.7% | 4.5% |
| Cash flow | ||||||||||||||||||
| Cash from operations | 72 | 77 | 90 | 65 | 57 | 81 | 12 | 106 | 149 | 167 | 165 | 181 | 157 | 116 | 180 | 205 | 196 | 176 |
| Capital spending | 20 | 16 | 22 | 41 | 19 | 25 | 45 | 59 | 47 | 45 | 48 | 47 | 53 | 75 | 120 | 105 | 91 | 95 |
| Free cash flow | 52 | 61 | 67 | 24 | 38 | 56 | −32 | 47 | 102 | 122 | 117 | 135 | 103 | 42 | 60 | 100 | 105 | 82 |
| Stock-based pay | 5 | 7 | 12 | 11 | 14 | 13 | 9 | 8 | 15 | 10 | 9 | 9 | 16 | 21 | 23 | 25 | 23 | 23 |
| Free cash flow after stock pay | 47 | 54 | 55 | 13 | 24 | 43 | −42 | 38 | 87 | 112 | 108 | 125 | 87 | 21 | 37 | 75 | 82 | 59 |
| Balance sheet | ||||||||||||||||||
| Cash | 38 | 23 | 37 | 20 | 35 | 77 | 82 | 52 | 44 | 26 | 14 | 49 | 18 | 24 | 24 | 47 | 17 | 14 |
| Total debt | 0 | 221 | 236 | 225 | 198 | 187 | 1,760 | 1,730 | 1,609 | 926 | 815 | 731 | 828 | 931 | 974 | 1,001 | 1,207 | 1,237 |
| Net debt (negative = net cash) | −38 | 198 | 199 | 205 | 162 | 110 | 1,678 | 1,678 | 1,565 | 900 | 801 | 682 | 810 | 907 | 950 | 954 | 1,190 | 1,223 |
| Diluted shares | 23m | 24m | 24m | 24m | 25m | 26m | 26m | 31m | 32m | 33m | 33m | 33m | 33m | 33m | 34m | 36m | 36m | 35m |
| Returned to shareholders | ||||||||||||||||||
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 50 | 100 |
| Total returned | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 50 | 100 |
| Quarter | 2024 Q4 Dec 2024 | 2025 Q1 Mar 2025 | 2025 Q2 Jun 2025 | 2025 Q3 Sept 2025 | 2025 Q4 Dec 2025 | 2026 Q1 Apr 2026 | 2026 Q2 Jul 2026 | 2026 Q3 Oct 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 449 | 437 | 476 | 468 | 472 | 440 | 464 | 450 |
| Gross profit | 117 | 120 | 129 | 126 | 125 | 110 | 113 | 102 |
| EBITDA | 86 | 79 | 92 | 89 | 91 | 67 | 69 | 63 |
| Operating income | 57 | 50 | 59 | 56 | 56 | 32 | 35 | 28 |
| Net income | 33 | −22 | 37 | 40 | 49 | 17 | 24 | 15 |
| Diluted EPS | $0.90 | −$0.66 | $1.04 | $1.11 | $1.37 | $0.48 | $0.69 | $0.43 |
| Growth (year on year) | ||||||||
| Revenue | +11.1% | +7.3% | +11.4% | +8.4% | +5.0% | +0.5% | −2.6% | −3.9% |
| EBITDA | +24.1% | +22.3% | +12.1% | +3.2% | +6.4% | −15.8% | −24.6% | −30.1% |
| Operating income | +31.0% | +28.0% | +8.9% | −2.7% | −1.9% | −35.7% | −41.8% | −50.0% |
| Net income | +24.1% | −209.6% | +18.4% | +12.0% | +48.6% | — | −36.2% | −62.3% |
| Diluted EPS | +15.4% | −211.9% | +18.2% | +12.1% | +52.2% | — | −33.7% | −61.3% |
| Margins | ||||||||
| Gross margin | 26.0% | 27.5% | 27.1% | 27.0% | 26.4% | 24.9% | 24.3% | 22.6% |
| EBITDA margin | 19.1% | 18.1% | 19.2% | 19.1% | 19.4% | 15.2% | 14.9% | 13.9% |
| Operating margin | 12.7% | 11.3% | 12.5% | 12.1% | 11.8% | 7.2% | 7.4% | 6.3% |
| Net margin | 7.3% | −5.1% | 7.8% | 8.5% | 10.3% | 3.8% | 5.1% | 3.3% |
| Free-cash-flow margin | 9.8% | 1.4% | 5.2% | 9.9% | 5.9% | 0.2% | 8.0% | 3.6% |
| Cash flow | ||||||||
| Cash from operations | 63 | 31 | 44 | 66 | 55 | 25 | 60 | 37 |
| Capital spending | 19 | 25 | 19 | 19 | 27 | 24 | 23 | 21 |
| Free cash flow | 44 | 6 | 25 | 46 | 28 | 1 | 37 | 16 |
| Stock-based pay | 6 | 7 | 6 | 5 | 6 | 7 | 5 | 5 |
| Free cash flow after stock pay | 38 | −1 | 19 | 41 | 22 | −6 | 32 | 11 |
| Last 12 months unless stated | ITGR | IART | MMSI | PEN | TFX | ENOV | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $1.8bn | $1.7bn | $1.6bn | $1.6bn | $2.3bn | $2.3bn | $99m |
| Revenue growth, last 12 months | −0.3% | 0.8% | 9.1% | 17.0% | 30.7% | 4.9% | 9.2% |
| Revenue growth, 3-year average | 6.7% | 2.4% | 9.5% | 16.2% | −8.0% | 12.2% | 13.5% |
| Revenue growth, latest quarter | −3.9% | 2.3% | 8.4% | 15.6% | 28.9% | 3.2% | 10.2% |
| Gross margin | 24.6% | 52.4% | 49.4% | 68.0% | 54.9% | 61.1% | 61.2% |
| Operating margin | 8.2% | 4.4% | 13.5% | 12.1% | 2.0% | −45.1% | −8.5% |
| Operating margin, 3-year average | 10.7% | −7.7% | 12.1% | 8.4% | 5.7% | −28.5% | −17.9% |
| Net margin | 5.7% | 0.8% | 9.9% | 10.1% | −45.8% | −48.0% | −12.0% |
| Cash from operations / revenue | 9.7% | 8.5% | 17.0% | 16.7% | 10.8% | 11.8% | −1.9% |
| Free-cash-flow margin | 4.5% | 5.2% | 12.4% | 12.8% | 7.5% | 2.8% | −3.9% |
| Free-cash-flow margin, 3-year average | 5.2% | 2.4% | 13.1% | 11.9% | 7.7% | −0.2% | −7.0% |
| Stock pay / revenue | 1.3% | 1.2% | 2.8% | 3.7% | 1.1% | 1.5% | 6.1% |
| Change in share count | −0.8% | 1.3% | −0.8% | 0.5% | −4.0% | 1.7% | 4.0% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | -0.3% | 9.1% | 102 of 129 |
| Change in growth rate Growth | -3.0pp | -0.6pp | 93 of 129 |
| Gross margin Profitability | 24.6% | 61.9% | 111 of 123 |
| Operating margin Profitability | 8.2% | -8.3% | 33 of 132 |
| Net margin Profitability | 5.7% | -12.0% | 38 of 133 |
| Free-cash-flow margin Cash generation | 4.5% | -3.4% | 44 of 128 |
| Stock pay as % of revenue Cash generation | 1.3% | 6.1% | 16 of 123 |
| Long-term debt as % of assets Balance sheet | 35.9% | 24.2% | 66 of 87 |
| Change in share count Balance sheet | -0.8% | 3.3% | 25 of 115 |
| Days sales outstanding Balance sheet | 69 days | 57 days | 82 of 118 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Cardio and Vascular | $1.1B | 59.7% | ▲ 16.6% |
| Cardiac Rhythm Management Neuromodulation | $669M | 36.1% | ▲ 1.2% |
| Other Markets | $77.8M | 4.2% | ▼ 26.9% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $980M | 52.9% | ▲ 4.4% |
| Rest of World | $470M | 25.3% | ▲ 8.8% |
| CR | $174M | 9.4% | ▲ 39.2% |
| PR | $131M | 7.1% | ▼ 4.2% |
| Ireland | $99.2M | 5.3% | ▲ 17.5% |
From Integer Holdings Corp's 10-K filed February 23, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Blackrock, Inc. | $500M | 5.4M | 13.1% | ▲ 0.9% |
| Invesco Ltd. | $210M | 2.2M | 5.5% | ▲ 14.1% |
| Vanguard Portfolio Management LLC | $191M | 2.0M | 5.0% | ▼ 0.3% |
| Dimensional Fund Advisors LP | $152M | 1.6M | 4.0% | ▲ 9.7% |
| Nomura Holdings Inc | $145M | 1.6M | 3.8% | ▲ 246.7% |
| Vanguard Capital Management LLC | $143M | 1.5M | 3.8% | ▼ 0.4% |
| State Street Corp | $132M | 1.4M | 3.5% | ▲ 1.1% |
| Morgan Stanley | $126M | 1.3M | 3.3% | ▼ 12.6% |
| Irenic Capital Management LP | $118M | 1.3M | 3.1% | 0.0% |
| Earnest Partners LLC | $94.2M | 1.0M | 2.5% | ▼ 3.1% |
| Hudson Bay Capital Management LP | $93.5M | 1.0M | 2.5% | 0.0% |
| Citadel Advisors LLC | $90.2M | 966K | 2.4% | ▲ 39.3% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Integer Holdings Corp's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.
| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Thor Kirk K Chief Human Resources Officer | September 15, 2026 | Sell | 11,767 | $126.23 | $1.5M |
| Thor Kirk K Chief Human Resources Officer | September 14, 2026 | Sell | 19,773 | $126.25 | $2.5M |
| Senn Andrew President, Growth & Innovation | September 8, 2026 | Sell | 9,408 | $126.30 | $1.2M |
| Thomas Tommy P VP, Corporate Controller | March 13, 2026 | Sell | 825 | $85.00 | $70,125 |
| Harris John A EVP, Global Ops and Manufactur | November 12, 2025 | Buy | 1,650 | $70.00 | $115,500 |
| Thomas Tommy P VP, Corporate Controller | November 11, 2025 | Sell | 884 | $70.15 | $62,013 |
| Smith Diron EVP, Chief Financial Officer | November 7, 2025 | Buy | 1,116 | $67.19 | $74,973 |
| Capps Cheryl C Director | November 6, 2025 | Buy | 1,600 | $66.70 | $106,720 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Next expected around February 18, 2027 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
